Suven Pharmaceuticals Limited (SUVENPHAR) — Cash Flow Reinvestment Rate
Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs255.04 Million. Check Suven Pharmaceuticals Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suven Pharmaceuticals Limited Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Suven Pharmaceuticals Limited across 7 annual periods. Explore Suven Pharmaceuticals Limited (SUVENPHAR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year capital reinvestment analysis for Suven Pharmaceuticals Limited. For live market cap and broader valuation context, see Suven Pharmaceuticals Limited (SUVENPHAR) total market value.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.43x | Rs4.11 Billion | Rs2.88 Billion | Rs1.56 Billion | ▲ +23.5% |
| 2024 | 1.15x | Rs4.14 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +8.4% |
| 2023 | 1.07x | Rs4.81 Billion | Rs4.51 Billion | Rs2.86 Billion | ▲ +168.0% |
| 2022 | 0.40x | Rs1.31 Billion | Rs3.30 Billion | Rs751.87 Million | ▼ -51.0% |
| 2021 | 0.81x | Rs3.11 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -20.4% |
| 2020 | 1.02x | Rs4.25 Billion | Rs4.16 Billion | Rs994.15 Million | ▼ -29.9% |
| 2019 | 1.46x | Rs733.40 Million | Rs504.05 Million | Rs567.86 Million | — |